Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Orchid Pharma Limited (NSE: ORCHPHARMA), ISIN INE191A01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ORCHPHARMA last traded at ₹887.00 (+2.19%), with a 52-week range of ₹480.00 to ₹1143.50 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 74.45%, FIIs 0.93%, DIIs 17.44%, mutual funds 16.88%.
EquiSense Score (ECS): 53/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.